Surface Oncology

-$0.03 (-1.71%) As of 4:11 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SURF and other ETFs, options, and stocks.

About SURF

Surface Oncology, Inc. operates as a clinical-stage immuno-oncology company. It focuses on biological pathways critical to the immunosuppressive tumor microenvironment and the development of next-generation cancer therapies.

CEO
Robert W. Ross
Employees
67
Headquarters
Cambridge, Massachusetts
Founded
2014

SURF Key Statistics

Market cap
93.93M
Price-Earnings ratio
—
Dividend yield
—
Average volume
659.56K
High today
$1.81
Low today
$1.72
Open price
$1.72
Volume
278.78K
52 Week high
$9.57
52 Week low
$1.71

SURF Earnings

-$0.52
$0.17
$0.87
$1.56
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure